Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Swing Therapeutics

548 Market Street, #27799
San Francisco, CA 94104
USA
6507993967
Website Company Summary Management Team
Management

CEO: Mike Rosenbluth (12/31/2019)
President/COO/Operations: Jeremy Frank (01/31/2021)
Technology: Nelson Mitchell (07/31/2019)
Board

Company

Business description: Swing Therapeutics has a goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development and validation of its pipeline of prescription-based digital therapies. Swing Therapeutics’ near-term goal is to validate its digital program for the treatment of fibromyalgia and bring it to market as an FDA-cleared, prescription-based digital therapeutic.
Capital

Rounds: 2
Recent Fundings: Jun 2022   Aug 2021
Capital raised: 19.3M
Last Round: 10.3M
Ownership: Private  
VCs include: AME Cloud VenturesJazz Venture Partners Alumni Ventures GroupMana Ventures;  Kicker Ventures;  Metrodora Ventures
Corporate investors: Asahi Kasei Corporate Ventures

Last Tweets


 

Last Mentions


Overview
Record updated: Jun 2022
Sector: Biotech
Year Founded: 2019
Headcount: 26-50 as of Jun 2022
Rounds: 2
Recent Fundings: Jun 2022   Aug 2021
Capital Raised: 19.3M
Last Round: 10.3M
Ownership: Private